2026年欧洲血液学协会年会（EHA 2026）将于6月11日至14日在瑞典斯德哥尔摩盛大召开。作为全球血液领域极具权威性与影响力的顶尖学术盛会，本届大会汇聚全球血液学领域权威专家、科研学者与临床医师，共享前沿进展，共探学科发展。本次EHA年会中，北京大学人民医院
研究名称：INTEGRATED GENOMIC AND TRANSCRIPTOMIC ANALYSES REVEAL BIOLOGICAL HETEROGENEITY OF ACCELERATED-PHASE CHRONIC MYELOID LEUKEMIA AND IDENTIFY A BLAST-PHASE-LIKE SUBGROUP
报告类型：Oral
研究名称：GENOMIC AND TRANSCRIPTOMIC FEATURES OF TRANSFORMED CHRONIC MYELOID LEUKEMIA IN BLAST PHASE
报告类型：Poster
研究名称：DIFFERENCES IN GENOMIC AND TRANSCRIPTOMIC FEATURES BETWEEN ADULTS WITH NEWLY DIAGNOSED BCR::ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE AND LYMPHOID-ONLY INVOLVEMENT
报告类型：Poster
研究名称：FRONT-LINE SECOND-GENERATION TKI THERAPY SIGNIFICANTLY IMPROVES THE SUCCESS RATE OF TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA: A MULTICENTER RETROSPECTIVE STUDY OF THE REAL WORLD
报告类型：Poster
审核：江倩教授团队
排版：Wyn
执行：Baa
戳“阅读原文”，查看更多内容
我要投稿
